Bengaluru, September 24, 2025: Medicap Healthcare Limited (“The Company”) has filed its Draft Red Herring Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI).
The company is a prominent player in the Indian pharmaceutical packaging sector, specializing in the production of pharmaceutical closures, including Euro Head caps and bottle preforms.
As of FY2025, the company’s 80.02% Revenue from Operations is from domestic sales and balance 19.98% is from exports to 14 countries. The Company has about 1.4% of the global market share and more than 40.00% domestic market share for Euro Head caps. (Source: F&S Report).
The company plans to raise fund through the Initial Public Offering. The total Issue size comprises of Fresh Issue aggregating up to ₹ 2,400 million (₹ 240 Crore) (“Total Issue Size”). There is no Offer-For-Sale component.
The objects of the Issue are to (i) Purchase of plant and machinery for the existing Manufacturing Unit, aggregating up to ₹ 743.70 million (₹ 74.37 Crore); (ii) Repayment or pre-payment, in full or part, of certain borrowings availed by the Company, aggregating up to ₹ 329.00 million (₹ 32.90 Crore); (iii) Investment in their Subsidiary KASR Healthcare Private Limited for Repayment or pre-payment, in full or part, of certain borrowings availed by the Company, aggregating up to ₹ 528.00 million (₹ 52.80 Crore); and balance for General Corporate Purposes. (“Objects of the Offer”).
Aryaman Financial Services Limited is the sole Book Running Lead Manager for the Issue.
